DIA gears up for Global Annual Meeting
DIA, the professional global community for healthcare product development, will host its in-person Global Annual Meeting in Chicago on June 19-23.
Archives for June 13, 2022
FDA advisory vote is boost for bluebird bio
Two of bluebird bio’s gene therapy candidates get the nod from FDA advisors.
Charles River and ASC Therapeutics expand gene therapy manufacturing agreement
Charles River Laboratories International and ASC Therapeutics have announced plans to manufacture ASC618, a second-generation gene therapy for hemophilia A.
Regenxbio: Bringing our manufacturing in-house allows us full control of the process
Regenxbio has officially opened its new gene therapy manufacturing facility.
AAVs – liquid treasure handled safely
Paid for and content provided by Single Use Support
Implementing safe handling of commercial AAVs vector manufacturing bear challenges. But there are process solutions to cope with scalable production of viral vectors.